Endometriosis Trial, Recruiting (NCT07065214)

Endometriosis Trial, Recruiting NCT07065214 Sponsor: Erbe Elektromedizin GmbH Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT07065214 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have symptoms that mean your doctor recommends surgery to treat a cyst on your ovary caused by endometriosis (called an endometrioma).
You are willing and able to sign a consent form agreeing to take part in the trial.

Who may not be able to join:

You are unable or unlikely to follow the trial requirements, or you are unable to understand what the trial involves.
You have previously had any procedure or surgery on your ovaries.
You have had an endometrioma (endometriosis cyst on the ovary) before that has come back — however, if you have endometriosis in other areas (such as on the lining of the abdomen) but not a returning ovarian cyst, you may still be eligible (confirm with trial site).
You are currently pregnant or breastfeeding.
You are taking part in another clinical study that could affect your AMH levels (a hormone linked to fertility) or your chances of getting pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bernhard Krämer, Prof. Dr. med., Department for Women's Health, Tuebingen, Germany

Phone: +49 70717552850

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07065214

Sponsor: Erbe Elektromedizin GmbH

Phase: Not Applicable

Status: Recruiting

Condition: Endometriosis

Trial contact: +49 70717552850

More information: https://clinicaltrials.gov/study/NCT07065214

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have symptoms that mean your doctor recommends surgery to treat a cyst on your ovary caused by endometriosis (called an endometrioma).
You are willing and able to sign a consent form agreeing to take part in the trial.

Who may not be able to join:

You are unable or unlikely to follow the trial requirements, or you are unable to understand what the trial involves.
You have previously had any procedure or surgery on your ovaries.
You have had an endometrioma (endometriosis cyst on the ovary) before that has come back — however, if you have endometriosis in other areas (such as on the lining of the abdomen) but not a returning ovarian cyst, you may still be eligible (confirm with trial site).
You are currently pregnant or breastfeeding.
You are taking part in another clinical study that could affect your AMH levels (a hormone linked to fertility) or your chances of getting pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Erbe Elektromedizin GmbH

Registry

ClinicalTrials.gov

Start date

26 November 2025

Est. completion

1 March 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Concentration of AMH (Anti-Müller hormone) level

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov